Clinical trials
Terminated Phase 2 Thyroid Cancer, Papillary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Day One Biopharmaceuticals, Inc. | 1 |
| Emory University | 1 |
| Grupo Espanol de Tumores Neuroendocrinos | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Hoffmann-La Roche | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Cancer, Papillary | 6 |
| Adenocarcinoma, Follicular | 4 |
| Thyroid Neoplasms | 4 |
| Colorectal Neoplasms | 2 |
| Melanoma | 2 |
| Pancreatic Neoplasms | 2 |
| Astrocytoma | 1 |
| Brain Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Bronchial Neoplasms | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.